DOL Identification in Pharma & Biotech

image 2026 01 21t115915.216
image 2026 01 21t115024.874

Define the brief and therapy scope

We start by clarifying therapy areas, markets, audience (HCP vs public), lifecycle stage and compliance constraints, so we know which types of digital activity are most relevant.


image 2026 01 21t115109.681

Discover relevant digital conversations

We map key hashtags, forums, platforms, congress feeds and publication sharing patterns to understand where meaningful professional conversation is happening for your topic.


image 2026 01 21t115157.999

Surface potential DOLs

We identify HCPs and experts who consistently contribute high‑quality content, generate genuine peer engagement and are closely associated with the disease or mechanism of interest.



image 2026 01 21t115258.798

Assess impact and credibility

We look beyond raw follower numbers to engagement quality, network position, offline credentials (publications, trials, roles) and consistency of scientific messaging.


Validate and segment

We validate candidates against your internal knowledge and compliance rules, then segment them (e.g. scientific DOLs, practical educators, community builders, regional voices) to support targeted engagement plans.

image 2026 01 21t115157.999
  • A curated, compliant list of digital opinion leaders aligned to your therapy areas and markets
  • Clear profiles combining offline expertise (research, clinical role) and online behaviour (channels, tone, typical topics)
  • Segmentation that shows who is best suited for education, peer‑to‑peer programmes, congress amplification or ongoing community building
  • Practical insight into which channels and formats matter most for your HCP audiences in each country or region

Why DOL identification matters for your strategy

As more HCPs consume data through virtual channels, DOLs have become a key bridge between formal evidence and everyday clinical practice. Including DOLs in your KOL strategy can:

  • Increase the reach and relevance of your scientific story in priority markets
  • Support launches and new indications with real‑time, peer‑level explanation of data
  • Help you understand emerging questions, misconceptions and unmet needs faster
  • Provide early signals on how new evidence is being interpreted in the field

When combined with traditional KOL identification and KOL mapping, DOL identification completes the picture of who truly shapes opinion across both offline and online environments.

How we help you use DOL insights

We design DOL identification outputs so that they are easy to activate:

  • Clear shortlists by market and specialty
  • Suggested engagement pathways that respect local regulations and roles
  • Integration with your existing KOL lists and segmentation
  • Input into content planning, congress strategies and virtual engagement programmes

If you already have KOL lists in place, we can layer DOL identification on top of them, highlighting overlaps, gaps and new opportunities so you can build a coherent, compliant expert strategy across channels.

Speak to us about how we can

help you identify the people who can impact the success of your brand and scientific story.